Absci

Absci is a pioneering biotechnology company that leverages generative artificial intelligence (AI) for drug creation.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

Search Tags

AI Drug Discovery, Biologics Development, Novel Target Identification

About Us

Absci is a biotechnology company that uses artificial intelligence to revolutionize the process of creating new biologic drugs. They specialize in designing antibodies from scratch using computer algorithms, bypassing traditional methods that rely on existing antibody libraries. Absci’s platform combines AI-driven design with rapid experimental validation to significantly reduce the time and cost typically associated with bringing new drug candidates to clinical trials.

Trending Companies in AI

Latest Articles in AI

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >
Anycubic Photon Mono M7 Pro for $469 with code AC30OFF. FREE $99 Gifts: 1*High Speed Resin+2*FEP Film+3000pcs Limited Mystery Box

CREATORS. DISRUPTORS. INNOVATORS.

Discover Emerging Technology Companies